Patents by Inventor Ronny MILDE

Ronny MILDE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CROSS-SPECIFIC ANTIGEN BINDING PROTEINS (ABP) TARGETING LEUKOCYTE IMMUNOGLOBULIN-LIKE RECEPTOR SUBFAMILY B1 (LILRB1) AND LILRB2, COMBINATIONS AND USES THEREOF
    Publication number: 20260209345
    Abstract: The invention relates to antigen binding proteins, such as antibodies, that bind to both leukocyte immunoglobulin-like receptor subfamily B1 (LILRB1) and LILRB2 while not binding to, or binding with significantly less affinity to, leukocyte immunoglobulin-like receptor subfamily A (LILRA), which can also inhibit the interaction between LILRB1 and/or LILRB2 and a natural ligand of LILRB receptors (interacting proteins, such as HLA-G) on immune cells and the inhibition of such interaction can reduce immune cell suppression and thereby support anti-infection and anti-tumour immune responses in a subject suffering from such diseases.
    Type: Application
    Filed: December 22, 2023
    Publication date: July 23, 2026
    Applicant: iOmx Therapeutics AG
    Inventors: Jonas ZANTOW, Jonas SCHILZ, Simone FRIEDRICH, Christina HARTL, Ronny MILDE, Maximilian AIGNER, Kritika SUDAN